Gilead 3rd-quarter results beat Wall Street estimates, raises outlook
By Deena Beasley (Reuters) -Gilead Sciences reported third-quarter financial results that handily beat Wall Street expectations on Wednesday as sales climbed 7%, leading the drugmaker to raise its outlook for full-year earnings. Gilead shares rose more than 3% after it reported its results and revised forecast. The Foster City, California-based company posted an adjusted quarterly …
Gilead 3rd-quarter results beat Wall Street estimates, raises outlook Read More »










